The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
Open accessAbstract
OBJECTIVE: Multiple sclerosis (MS) is associated with chronic symptoms, including muscle stiffness, spasms, pain and insomnia. Here we report the results of the Multiple Sclerosis and Extract of Cannabis (MUSEC) study that aimed to substantiate the patient based findings of previous studies. PATIENTS AND METHODS: Patients with stable MS at 22 UK centres were randomised to oral cannabis extract (CE) (N=144) or placebo (N=135), stratified by centre, walking ability and use of antispastic medication. This double blind, placebo controlled, phase III study had a screening period, a 2 week dose titration phase from 5 mg to a maximum of 25 mg of tetrahydrocannabinol daily and a 10 week maintenance phase. The primary outcome measure was a category rating scale (CRS) measuring patient reported change in muscle stiffness from baseline. Further CRSs assessed body pain, spasms and sleep quality. Three validated MS specific patient reported outcome measures assessed aspects of spasticity, physical and psychological impact, and walking ability. RESULTS: The rate of relief from muscle stiffness after 12 weeks was almost twice as high with CE than with placebo (29.4% vs. 15.7%; OR 2.26; 95% CI 1.24 to 4.13; p=0.004, one sided). Similar results were found after 4 weeks and 8 weeks, and also for all further CRSs. Results from the MS scales supported these findings. CONCLUSION: The study met its primary objective to demonstrate the superiority of CE over placebo in the treatment of muscle stiffness in MS. This was supported by results for secondary efficacy variables. Adverse events in participants treated with CE were consistent with the known side effects of cannabinoids. No new safety concerns were observed. TRIAL REGISTRATION NUMBER: NCT00552604.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Probabilistic Models for Some Intelligence and Attainment Tests
(1961) · Information and Control · doi:10.1016/s0019-9958(61)80061-2 · Cited by 6,939
Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998) · JAMA · doi:10.1001/jama.280.18.1569 · Cited by 6,658
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A Rating Formulation for Ordered Response Categories
Andrich, D. (1978) · Psychometrika · doi:10.1007/bf02293814 · Cited by 2,970
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Hobart, J. (2001) · Brain · doi:10.1093/brain/124.5.962 · Cited by 1,120
Self-citationZajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Self-citationMeasuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12)
Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003) · Neurology · doi:10.1212/wnl.60.1.31 · Cited by 821
Self-citationHobart, J., & Cano, S. (2009) · Health Technology Assessment · doi:10.3310/hta13120 · Cited by 621
Self-citationHobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70290-9 · Cited by 495
Self-citationNovotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03328.x · Cited by 475
Casagrande, J. T., Pike, M. C., & Smith, P. G. (1978) · Biometrics · doi:10.2307/2530613 · Cited by 431
Stop using the Ashworth Scale for the assessment of spasticity
Fleuren, J. F. M., Voerman, G. E., Erren-Wolters, C. V., Snoek, G. J., Rietman, J. S., Hermens, H. J., & Nene, A. V. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.177071 · Cited by 428
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
Collin, C., Davies, P., Mutiboko, I. K., Ratcliffe, S., & for the Sativex Spasticity in MS Study Group (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01639.x · Cited by 379
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
Zajicek, J. P. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.070136 · Cited by 335
Vaney, C., Heinzel-Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1048oa · Cited by 262
Hobart, J. C., Riazi, A., Thompson, A. J., Styles, I. M., Ingram, W., Vickery, P. J., Warner, M., Fox, P. J., & Zajicek, J. P. (2006) · Brain · doi:10.1093/brain/awh675 · Cited by 177
Self-citationUtilization of unconventional treatments by persons with MS: Is it alternative or complementary?
Schwartz, C. E., Laitin, E., Brotman, S., & LaRocca, N. G. (1999) · Neurology · doi:10.1212/wnl.52.3.626 · Cited by 82
Early Puberty: What Is Normal and When Is Treatment Indicated?
Ritzén, E. M. (2003) · Hormone Research in Paediatrics · doi:10.1159/000074497 · Cited by 67
Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles
Jean Aicardi, P. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-0357-3 · Cited by 41
Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
Wassmer, G. (2003) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-120024196 · Cited by 10
Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles (3rd Edition)
Devi, G. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.381 · Cited by 9
Measurement of neurological outcomes
Hobart, J. C., & Thompson, A. J. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9781316134993.008 · Cited by 4
Self-citation
Cited by
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 641
Cannabis-based medicines for chronic neuropathic pain in adults
Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub2 · Cited by 571
Hill, K. P. (2015) · JAMA · doi:10.1001/jama.2015.6199 · Cited by 508
Metadata
- Authors
- Zajicek, J. P., Hobart, J. C., Slade, A., Barnes, D., Mattison, P. G., & on behalf of the MUSEC Research Group
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2012-07-12
- Volume
- 83
- Issue
- 11
- Pages
- 1125-1132
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2105601238
- Cited by
- 278
- References
- 24
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.